Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisRaymond L. Comenzo, Giampaolo Merlini, Vaishali Sanchorawala et al.|Leukemia|2012Cited by 383
Twin randomized studies of daratumumab (DARA; D) plus standard of care (lenalidomide/dexamethasone or bortezomib/dexamethasone [DRd or DVd]) versus Rd or Vd alone in relapsed or refractory multiple myeloma (MM): 54767414MMY3003 (Pollux) and 54767414MMY3004 (Castor).Antonio Palumbo, Robert Z. Orlowski, Meletios Α. Dimopoulos et al.|Journal of Clinical Oncology|2015Cited by 6